We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Evaluation of Effectiveness of Acupuncture on Quality of Life in Patients With Breast Cancer Receiving Chemotherapy

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT01727362
First Posted: November 16, 2012
Last Update Posted: July 24, 2017
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborators:
Mammazentrum Hamburg am Krankenhaus Jerusalem, Germany
Dorit und Alexander Otto Stiftung, Hamburg, Germany
Information provided by (Responsible Party):
Claudia M. Witt, Charite University, Berlin, Germany
  Purpose
The aim of this trial is to investigate the effectiveness of acupuncture on quality of life in patients with breast cancer receiving chemotherapy compared to routine care.

Condition Intervention
Breast Cancer Other: Usual care + acupuncture Other: Usual care

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Evaluation of Effectiveness of Acupuncture on Quality of Life in Patients With Breast Cancer Receiving Chemotherapy- A Pragmatic Randomized Trial

Resource links provided by NLM:


Further study details as provided by Claudia M. Witt, Charite University, Berlin, Germany:

Primary Outcome Measures:
  • Functional Assessment of Cancer Therapy - Breast Cancer (FACT-B) [ Time Frame: 6 month ]

Secondary Outcome Measures:
  • Functional Assessment of Cancer Therapy - Breast Cancer (FACT-B) [ Time Frame: 3 month ]

Other Outcome Measures:
  • Subscales of the Functional Assessment of Cancer Therapy - General (FACT-G): physical well-being, social/family well-being, emotional well-being, functional well-being [ Time Frame: 3 month ]
  • Subscales of the Functional Assessment of Cancer Therapy - General (FACT-G): physical well-being, social/family well-being, emotional well-being, functional well-being [ Time Frame: 6 month ]
  • Subscale for Breast Cancer of the Functional Assessment of Cancer Therapy - Breast Cancer (FACT-B) [ Time Frame: 3 month ]
  • Subscale for Breast Cancer of the Functional Assessment of Cancer Therapy - Breast Cancer (FACT-B) [ Time Frame: 6 month ]
  • Pain, quality of sleep, and nausea (single items of the FACT-B) [ Time Frame: 3 month ]
  • Pain, quality of sleep, and nausea (single items of the FACT-B) [ Time Frame: 6 month ]
  • Functional Assessment of Chronic Illness Therapy-Fatigue [ Time Frame: 3 month ]
  • Functional Assessment of Chronic Illness Therapy-Fatigue [ Time Frame: 6 month ]
  • FACT/GOG-NTX, polyneuropathy symptoms [ Time Frame: 3 month ]
  • FACT/GOG-NTX, polyneuropathy symptoms [ Time Frame: 6 month ]
  • Quality of Life (SF-12 Health Survey) [ Time Frame: 3 month ]
  • Quality of Life (SF-12 Health Survey) [ Time Frame: 6 month ]
  • Survival without relapse [ Time Frame: 6 month ]
  • Survival [ Time Frame: 6 month ]
  • Adverse effects and Interactions [ Time Frame: 3 month ]
  • Adverse effects and Interactions [ Time Frame: 6 month ]
  • Satisfaction and patient-reported effectiveness [ Time Frame: 3 month ]
    This will only be assessed in the acupuncture arm

  • Satisfaction and patient-reported effectiveness [ Time Frame: 6 month ]
    This will only be assessed in the acupuncture arm

  • Goal Attainment Scale [ Time Frame: 3 month ]
    This will only be assessed in the acupuncture arm

  • Goal Attainment Scale [ Time Frame: 6 month ]
    This will only be assessed in the acupuncture arm

  • Laboratory parameters (hemoglobin, leukocytes, blood plates, liver values, kidney values) [ Time Frame: 3 month ]
  • Laboratory parameters (hemoglobin, leukocytes, blood plates, liver values, kidney values) [ Time Frame: 6 month ]

Estimated Enrollment: 140
Study Start Date: October 2012
Study Completion Date: December 2016
Primary Completion Date: December 2016 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Active Comparator: Usual care + acupuncture Other: Usual care + acupuncture
Patients of this group receive a semi-standardized acupuncture treatment over 6 month in addition to usual care
Active Comparator: Usual care Other: Usual care
Patients of this group receive usual care only

Detailed Description:
At the Mammazentrum Hamburg, Germany, patients with breast cancer receiving chemotherapy have the opportunity to get acupuncture in addition to conventional therapy to maintain quality of life and to reduce the side effects of the chemotherapy such as gastrointestinal disorders. In this randomized trial we aim to investigate the effectiveness of additional acupuncture compared to routine care in patients with breast cancer.
  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • diagnosed breast cancer (invasive, intraductal, hormone-sensitive and not hormone-sensitive, only locoregional metastases)
  • current chemotherapy at Mammazentrum Hamburg with regimen FEC/DOC or EC/DOC
  • willingness to receive acupuncture within the next 6 month if randomized in acupuncture group
  • willingness to refrain from acupuncture within the next 6 month if randomized in control group
  • informed consent

Exclusion Criteria:

  • distant metastases
  • blood coagulation disorder and/or current use of anticoagulants
  • serious acute or chronic mental or physical disorders
  • clinically relevant cardiac arrhythmia symptoms
  • insufficient German language ability
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01727362


Locations
Germany
Mammazentrum Hamburg am Krankenhaus Jerusalem
Hamburg, Germany, 20357
Sponsors and Collaborators
Charite University, Berlin, Germany
Mammazentrum Hamburg am Krankenhaus Jerusalem, Germany
Dorit und Alexander Otto Stiftung, Hamburg, Germany
Investigators
Principal Investigator: Martin Carstensen, Prof. MD Mammazentrum am Krankenhaus Jerusalem, Hamburg, Germany
  More Information

Responsible Party: Claudia M. Witt, Professor, MD, Charite University, Berlin, Germany
ClinicalTrials.gov Identifier: NCT01727362     History of Changes
Other Study ID Numbers: ACU in breast cancer
First Submitted: November 7, 2012
First Posted: November 16, 2012
Last Update Posted: July 24, 2017
Last Verified: July 2017

Keywords provided by Claudia M. Witt, Charite University, Berlin, Germany:
Breast Cancer
Acupuncture
Quality of Life

Additional relevant MeSH terms:
Breast Neoplasms
Neoplasms by Site
Neoplasms
Breast Diseases
Skin Diseases